US-based biotechnology company Seismic Therapeutic has dosed the initial cohort of healthy participants in a randomised Phase I trial of S-1117, a treatment for autoimmune diseases. The double ...

March 11, 2025--(BUSINESS WIRE)--Seismic Therapeutic, Inc., the machine learning immunology company, today announced the dosing of the first healthy subject cohort in a Phase 1 clinical trial of S ...

That is because the key rates-FX transmission channel – the 2-year swap rate differential – has tightened significantly too.

Results indicate significant seismic hazard variability, with Jazan showing high seismic risks with an MCER SA (0.2 s) of 0.45 g, compared to Najran’s lower risks at 0.23 g. Structural design ...

To address this, we introduce an inverse scattering approach to frequency-domain seismic FWI by utilizing a regularized objective function ... scattering problem into a series of linear inverse ...

OpenQuake Model Building Toolkit, a suite of tools for building components and analysing models for PSHA.

Results indicate significant seismic hazard variability, with Jazan showing high seismic risks with an MCER SA (0.2 s) of 0.45 g, compared to Najran’s lower risks at 0.23 g. Structural design ...